Menopause treatment options

Match the symptom to the treatment conversation

More columns are available. Swipe left to see them.

Hormone therapy: systemic or local?

Systemic hormone therapy sends estrogen through the bloodstream via a pill, patch, gel, spray, or systemic ring. It is used primarily for bothersome hot flashes and night sweats and also prevents bone loss while used. A person with a uterus generally needs a progestogen with systemic estrogen to protect the uterine lining.

Low-dose vaginal estrogen acts mainly in vaginal and urinary tissues. It can treat dryness, irritation, pain with sex, and some urinary symptoms with much less systemic exposure. It does not treat hot flashes.

The decision changes with age, time since menopause, uterus status, pregnancy potential, bleeding, cancer and clot history, cardiovascular and liver health, migraine, route preference, and current medicines. Compare menopause hormone therapy benefits, routes, and risks.

Nonhormone options for hot flashes

The Menopause Society recommends several evidence-based prescription approaches for vasomotor symptoms, including certain antidepressants (SSRIs/SNRIs), gabapentin, fezolinetant, and oxybutynin. The FDA approved elinzanetant (Lynkuet) in October 2025 for moderate-to-severe hot flashes due to menopause, adding another nonhormone option. Only some products have a specific FDA indication for menopause hot flashes; others may be used off label based on evidence and clinical judgment.

These are not interchangeable. Fezolinetant carries a boxed warning for rare but serious liver injury. Liver tests are required before treatment, monthly for the first 3 months, then at months 6 and 9. Elinzanetant labeling calls for liver tests before treatment and at 3 months and warns about drowsiness or daytime impairment, pregnancy loss, and seizure history. It says to avoid grapefruit or grapefruit juice and medicines that strongly raise or lower elinzanetant levels; some other interacting medicines require a lower dose.

Side effects, other medicines, blood pressure, sleep needs, and personal preference shape the choice. Clonidine and many supplements have weaker benefit or less favorable tradeoffs and should not be presented as equivalent options.

See a focused comparison for hot flashes and night sweats.

Vaginal and urinary symptoms often need local care

Lubricants reduce friction during sexual activity. Vaginal moisturizers are used regularly to improve day-to-day moisture. Persistent genitourinary syndrome of menopause can be treated with low-dose vaginal estrogen, vaginal DHEA (prasterone), or oral ospemifene. Pelvic-floor physical therapy can help when muscle tension or weakness contributes to pain or urinary symptoms.

A history of breast cancer or another estrogen-sensitive condition calls for shared decision-making with the relevant clinician, especially when nonhormone measures have not helped. Review the full vaginal dryness treatment comparison.

Sleep and mood need their own diagnosis

Treating night sweats can improve sleep when heat is the trigger. Persistent insomnia responds to cognitive behavioral therapy for insomnia (CBT-I), which is more than basic sleep-hygiene tips. Loud snoring, gasping, witnessed breathing pauses, morning headaches, or marked daytime sleepiness points toward sleep-apnea assessment.

Depression and anxiety can emerge or recur during the menopause transition, but symptoms should receive standard mental-health assessment. Seek immediate help for thoughts of self-harm, mania, psychosis, or inability to stay safe.

Use the menopause sleep pattern chooser to identify what wakes you.

What about supplements and “natural” remedies?

“Natural” does not establish effectiveness, purity, or safety. Evidence for many marketed menopause supplements is inconsistent, and products can interact with medicines or contain variable ingredients. Compounded hormones are not automatically safer or more effective than FDA-approved formulations.

If you want to try a supplement, bring the exact bottle and dose to a pharmacist or clinician. Ask what outcome to track, how long to test it, what side effects or interactions matter, and when to stop.

What to bring to your appointment

The treatment mini quiz offers symptom-specific comparisons and questions to discuss. Bring the records below to help a clinician assess your options.

Bring:

1. One priority: the symptom you most want to improve and how it affects life.
2. A short pattern: when it happens, frequency, severity, triggers, period changes, and what you tried.
3. Health history: uterus and ovary status; bleeding; pregnancy possibility; cancer, clot, stroke, heart, liver, migraine, bone, mood, and sleep history.
4. Every product: prescriptions, nonprescription medicines, vitamins, and supplements.
5. Your constraints: route, side effects, contraception, cost, coverage, and how much monitoring is realistic.

Ask: “Which option is most likely to improve my priority symptom, what benefit should I expect, what are the main risks for me, and when will we reassess?”

Use the menopause treatment priorities quiz for a more detailed preparation checklist. It cannot recommend a medicine or establish treatment eligibility.

When symptoms need assessment before treatment

Report bleeding after menopause, bleeding after sex, a breast lump, recurrent urinary symptoms, new severe pelvic pain, or symptoms beginning before 45. Seek emergency care for chest pain, severe shortness of breath, sudden weakness or trouble speaking, a sudden severe headache, or thoughts of self-harm.